Tai Y-T, Fulciniti M, Hideshima T, Song W, Leiba M, Li X-F, Rumizen M, Burger P, Morrison A, Podar K, Chauhan D, Tassone P, Richardson P, Munshi NC, Ghobrial IM, Anderson KC. Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis. Blood. 2007;110(5):1656-1663
- PMID: 39231434
- PMCID: PMC11864212
- DOI: 10.1182/blood.2024026818
Tai Y-T, Fulciniti M, Hideshima T, Song W, Leiba M, Li X-F, Rumizen M, Burger P, Morrison A, Podar K, Chauhan D, Tassone P, Richardson P, Munshi NC, Ghobrial IM, Anderson KC. Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis. Blood. 2007;110(5):1656-1663
Abstract
This article has been retracted; please see Elsevier's Article Correction, Retraction and Removal Policy (Article withdrawal | Elsevier policy).This article has been retracted at the request of the Editors and authors.Within the paper, image issues were identified in Figures 1, 4, and 6. Images within these figures show duplication, modification, or unmarked splices.The authors state that these figures cannot be used to support the conclusions of the paper.Authors Tai, Fulciniti, Song, Li, Morrison, Chauhan, Tassone, Ghobrial, and Anderson approve the retraction. Authors Hideshima, Leiba, Rumizen, Burger, Podar, Richardson, and Munshi did not respond.
© 2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Retraction of
-
Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis.Blood. 2007 Sep 1;110(5):1656-63. doi: 10.1182/blood-2007-03-081240. Epub 2007 May 17. Blood. 2007. Retraction in: Blood. 2024 Oct 10;144(15):1648. doi: 10.1182/blood.2024026818. PMID: 17510321 Free PMC article. Retracted. Clinical Trial.
Similar articles
-
Xu H, Cao Y, Yang X, Cai P, Kang L, Zhu X, Luo H, Lu L, Wei L, Bai X, Zhu Y, Zhao B-Q, Fan W. ADAMTS13 controls vascular remodeling by modifying VWF reactivity during stroke recovery. Blood. 2017;130(1):11-22.Blood. 2025 Jan 30;145(5):550. doi: 10.1182/blood.2024028134. Blood. 2025. PMID: 39689272 Free PMC article.
-
Wilkins CR, Zwicker JI, Derkach A, Burge M. Impact of romiplostim on overall survival in chemotherapy induced thrombocytopenia. Blood. 2023;142(suppl 1):801-802.Blood. 2024 Dec 12;144(24):2560. doi: 10.1182/blood.2024024692. Blood. 2024. PMID: 38493486
-
RETRACTED: MicroRNA-34 suppresses proliferation of human ovarian cancer cells by triggering autophagy and apoptosis and inhibits cell invasion by targeting Notch 1.Biochimie. 2019 May;160:193-199. doi: 10.1016/j.biochi.2019.03.011. Epub 2019 Mar 21. Biochimie. 2019. Retraction in: Biochimie. 2023 Mar;206:154. doi: 10.1016/j.biochi.2023.02.003. PMID: 30905732 Retracted.
-
Retraction notice to "Globularifolin exerts anticancer effects on glioma U87 cells through inhibition of Akt/mTOR and MEK/ERK signaling pathways in vitro and inhibits tumor growth in vivo" [Biochmie 142C (2017) 144-151].Biochimie. 2023 Jan;204:170. doi: 10.1016/j.biochi.2022.11.007. Biochimie. 2023. PMID: 36623909
-
RETRACTED: TRPV6 calcium channel regulation, downstream pathways, and therapeutic targeting in cancer.Cell Calcium. 2019 Jun;80:117-124. doi: 10.1016/j.ceca.2019.04.006. Epub 2019 Apr 22. Cell Calcium. 2019. Retraction in: Cell Calcium. 2020 Mar;86:102126. doi: 10.1016/j.ceca.2019.102126. PMID: 31055179 Retracted. Review.
References
Publication types
LinkOut - more resources
Full Text Sources